Quantitative Evaluation of Model‐Informed Drug Development Implementation in China's Approved Innovative Drugs: From Policy to Practice (2018–2024)

ABSTRACT Model‐informed drug development (MIDD) has emerged as a cornerstone paradigm in global pharmaceutical innovation. Historically underutilized in China, MIDD methodologies gained momentum following the National Medical Products Administration's (NMPA) 2020 release of the Model‐Informed Drug D...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jian Li, Zhenlei Wang, Chunmin Wei, Ruirui He, Qingyu Yao
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2026-02-01
סדרה:	CPT: Pharmacometrics & Systems Pharmacology
נושאים:	exposure response model informed drug development physiology‐based pharmacokinetics population pharmacokinetics
גישה מקוונת:	https://doi.org/10.1002/psp4.70211
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!